215 related articles for article (PubMed ID: 29209232)
1. The Clinicopathological and Prognostic Implications of FoxP3
Xu P; Fan W; Zhang Z; Wang J; Wang P; Li Y; Yu M
Front Physiol; 2017; 8():950. PubMed ID: 29209232
[No Abstract] [Full Text] [Related]
2. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.
Shou J; Zhang Z; Lai Y; Chen Z; Huang J
BMC Cancer; 2016 Aug; 16(1):687. PubMed ID: 27566250
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis.
Zhou Y; Shao N; Aierken N; Xie C; Ye R; Qian X; Hu Z; Zhang J; Lin Y
J Cancer; 2017; 8(19):4098-4105. PubMed ID: 29187886
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.
Zhao S; Jiang T; Zhang L; Yang H; Liu X; Jia Y; Zhou C
Oncotarget; 2016 Jun; 7(24):36065-36073. PubMed ID: 27153545
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating FoxP3
Hu G; Li Z; Wang S
Oncotarget; 2017 Sep; 8(43):75361-75371. PubMed ID: 29088871
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of Forkhead box P3 regulatory T cells in biliary tract cancer: A systematic review and meta-analysis.
Cai P; Wu Z; Yang X; Wang N; Yang Y
Medicine (Baltimore); 2023 Dec; 102(50):e36608. PubMed ID: 38115302
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis.
Shang B; Liu Y; Jiang SJ; Liu Y
Sci Rep; 2015 Oct; 5():15179. PubMed ID: 26462617
[TBL] [Abstract][Full Text] [Related]
9. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
Gai XD; Song Y; Li C; Lei YM; Yang B
Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
[TBL] [Abstract][Full Text] [Related]
10.
Gai XD; Li C; Song Y; Lei YM; Yang BX
Biomed Rep; 2013 Mar; 1(2):207-212. PubMed ID: 24648920
[TBL] [Abstract][Full Text] [Related]
11. Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3
Yan B; Xiong J; Ye Q; Xue T; Xiang J; Xu M; Li F; Wen W
BMC Gastroenterol; 2022 Mar; 22(1):122. PubMed ID: 35296257
[TBL] [Abstract][Full Text] [Related]
12. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis.
Huang Y; Liao H; Zhang Y; Yuan R; Wang F; Gao Y; Wang P; Du Z
PLoS One; 2014; 9(5):e94376. PubMed ID: 24827118
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of FOXP3
Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M
BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
17. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
18. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical distribution of FOXP3+ regulatory T cells in colorectal cancer patients.
Ling ZA; Zhang LJ; Ye ZH; Dang YW; Chen G; Li RL; Zeng JJ
Int J Clin Exp Pathol; 2018; 11(4):1841-1854. PubMed ID: 31938291
[No Abstract] [Full Text] [Related]
20. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
Hu L; Zhu M; Shen Y; Zhong Z; Wu B
World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]